Nasdaq · CIK 0001588978
PRCT PROCEPT BioRobotics Corp
Insider trading from SEC Form 4. Last filing 8 d ago. Close $18.40 on Oct 9, 2026, +10% from the 52-week low and -50% from the high.
In brief
PROCEPT BioRobotics Corp (PRCT) has 54 SEC Form 4 filings on file from 16 insiders, the latest filed on Oct 5, 2026. In the last 90 days insiders made 1 open-market buy worth $498k and 3 open-market sells worth $22k, net +$476k.
26 open-market trades have been scored at PRCT. The newest: Alaleh Nouri (EVP, CLO, CORP. SEC.) sold $6,223 of stock on Sep 9, 2026, filed Sep 10, 2026, scored 30 (weak). The largest of the 26 shown: Reza Zadno (President, CEO) sold $26M on Oct 30, 2024, scored 63 (notable). 3 insiders sold within 14 days of each other around Sep 9, 2026.
25 Form 144 notices of planned sales are on file, the latest filed Sep 9, 2026.
Last 90 days
Net insider value
+$476k
more bought than sold
Buys
1
$498k by 1 insider
Sells
3
$22k by 3 insiders
Insiders on file
16
with a Form 4 at this company
Price and insider trades, last year
PRCTOct 9, 2026 · close 18.40
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at PROCEPT BioRobotics Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Alaleh Nouri EVP, CLO, CORP. SEC. sell | $6,223 297 shares | -0% | +24% from low-48% from high | |
| 30Weak | Barry L Templin EVP, Chief Technology Officer sell | $7,815 373 shares | -0% | +24% from low-48% from high | |
| 37Weak | Kevin Waters EVP, CFO sell | $7,815 373 shares | -0% | +24% from low-48% from high | |
| 59Moderate | Larry L Wood President, CEO buy | $498k 23,900 shares | - | +22% from low-51% from high | |
| 30Weak | Alaleh Nouri EVP, CLO, CORP. SEC. sell | $8,117 285 shares | -0% | +31% from low-56% from high | |
| 30Weak | Barry L Templin EVP, Chief Technology Officer sell | $10k 358 shares | -1% | +31% from low-56% from high | |
| 37Weak | Kevin Waters EVP, CFO sell | $10k 357 shares | -0% | +31% from low-56% from high | |
| 23Weak | Alaleh Nouri EVP, CLO, CORP. SEC. sell | $8,559 304 shares | -0% | +21% from low-58% from high | |
| 14Weak | Alaleh Nouri EVP, CLO, CORP. SEC. sell | $139k 5,363 shares | -5% | +13% from low-61% from high | |
| 30Weak | Kevin Waters EVP, CFO sell | $20k 706 shares | -0% | +21% from low-58% from high | |
| 12Weak | Alaleh Nouri EVP, CLO, CORP. SEC. sell | $83k 3,243 shares | -3% | +7% from low-63% from high | |
| 56Moderate | Antal Rohit Desai director buy | $10M 426,262 shares | - | +12% from low-61% from high | |
| 34Weak | Alaleh Nouri EVP, CLO, CORP. SEC. sell | $163k 6,892 shares | -6% | +7% from low-63% from high | |
| 41Moderate | Kevin Waters EVP, CFO sell | $159k 6,721 shares | -4% | +7% from low-63% from high | |
| 55Moderate | Frederic H Moll director buy | $785k 20,000 shares | +2% | +5% from low-59% from high | |
| 48Moderate | Antal Rohit Desai director sell | $4.7M 75,000 shares | -84% | +32% from low-35% from high | |
| 38Weak | Hisham Shiblaq EVP, Chief Comm. Officer sell | $1.3M 20,000 shares | -24% | +29% from low-37% from high | |
| 38Weak | Antal Rohit Desai director sell | $4.7M 75,000 shares | -46% | +23% from low-40% from high | |
| 23Weak | Alaleh Nouri EVP, CLO, CORP. SEC. sell | $2.7M 28,092 shares | -35% | - | |
| 43Moderate | Reza Zadno President, CEO sell | $2.6M 26,423 shares | -15% | - | |
| 43Moderate | Reza Zadno President, CEO sell | $2.6M 26,420 shares | -13% | - | |
| 43Moderate | Reza Zadno President, CEO sell | $2.4M 26,420 shares | -11% | - | |
| 43Moderate | Reza Zadno President, CEO sell | $2.5M 26,420 shares | -10% | - | |
| 38Weak | Antal Rohit Desai director sell | $9.6M 100,000 shares | -38% | - | |
| 63Notable | Reza Zadno President, CEO sell | $26M 288,461 shares | -53% | - | |
| 17Weak | Kevin Waters EVP, CFO sell | $1.8M 25,000 shares | -21% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 9, 2026 | Nouri Alaleh Officer | 297 0.00% of outstanding | $6,223 | Sep 9, 2026 | none |
| Sep 9, 2026 | Waters Kevin Officer | 373 0.00% of outstanding | $7,816 | Sep 9, 2026 | none |
| Sep 9, 2026 | Templin Barry L Officer | 373 0.00% of outstanding | $7,816 | Sep 9, 2026 | none |
| Jun 8, 2026 | Nouri Alaleh Officer | 285 0.00% of outstanding | $8,117 | Jun 8, 2026 | $8,559 |
| Jun 8, 2026 | Templin Barry L Officer | 358 0.00% of outstanding | $10k | Jun 8, 2026 | $25k |
| Jun 8, 2026 | Waters Kevin Officer | 357 0.00% of outstanding | $10k | Jun 8, 2026 | $20k |
| Mar 19, 2026 | Alalah Nouri Officer | 5,363 0.01% of outstanding | $140k | Mar 19, 2026 | $83k |
| Mar 17, 2026 | Nouri Alaleh Officer | 304 0.00% of outstanding | $8,559 | Mar 17, 2026 | $163k |
| Mar 17, 2026 | Waters Kevin Officer | 706 0.00% of outstanding | $20k | Mar 17, 2026 | $159k |
| Mar 10, 2026 | Alalah Nouri Officer | 3,243 0.01% of outstanding | $82k | Mar 10, 2026 | none |
| Mar 6, 2026 | Nouri Alaleh Officer | 6,892 0.01% of outstanding | $163k | Mar 6, 2026 | none |
| Mar 6, 2026 | Waters Kevin Officer | 6,721 0.01% of outstanding | $159k | Mar 6, 2026 | none |
| Jun 6, 2025 | SHAM SHIBLAQ Officer, Director | 20,000 0.04% of outstanding | $1.3M | Jun 6, 2025 | none |
| Jun 3, 2025 | 222 DNA TRUST Director | 150,000 0.27% of outstanding | $8.7M | Jun 3, 2025 | none |
| Mar 18, 2025 | Nouri Alaleh Officer | 316 0.00% of outstanding | $18k | Mar 18, 2025 | $223k |
| Mar 18, 2025 | Shiblaq Hisham Officer | 247 0.00% of outstanding | $14k | Mar 18, 2025 | $220k |
| Mar 18, 2025 | Waters Kevin Officer | 733 0.00% of outstanding | $42k | Mar 18, 2025 | $225k |
| Mar 18, 2025 | Zadno Reza Officer, Director | 5,475 0.01% of outstanding | $312k | Mar 18, 2025 | $976k |
| Mar 6, 2025 | Nouri Alaleh Officer | 3,641 0.01% of outstanding | $223k | Mar 6, 2025 | none |
| Mar 6, 2025 | Shiblaq Hisham Officer | 3,588 0.01% of outstanding | $220k | Mar 6, 2025 | none |
| Mar 6, 2025 | Waters Kevin Officer | 3,662 0.01% of outstanding | $225k | Mar 6, 2025 | none |
| Mar 6, 2025 | Zadno Reza Officer | 15,916 0.03% of outstanding | $976k | Mar 6, 2025 | none |
| Dec 4, 2024 | Alalah Nouri Officer | 56,185 0.11% of outstanding | $5.5M | Dec 4, 2024 | none |
| Dec 4, 2024 | REZA ZADNO Director, Officer | 26,423 0.05% of outstanding | $2.5M | Dec 4, 2024 | $7.5M |
| Nov 27, 2024 | REZA ZADNO Director, Officer | 26,420 0.05% of outstanding | $2.6M | Nov 27, 2024 | $4.9M |
Transactions
The newest 50 of 156 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Michael Mack director | AGrant or award Common Stock | +7,727 | $0.00 | $0 | 7,727 | 8 d ago |
| Oct 2, 2026 | Michael Mack director | AGrant or award Stock Option (Right to Buy)derivative | +12,191 | $0.00 | $0 | 12,191 | 8 d ago |
| Sep 9, 2026 | Kevin Waters EVP, CFO | SOpen-market sale Common Stock | -373 | $20.95 | $7,815 | 180,355 | 33 d ago |
| Sep 9, 2026 | Barry L Templin EVP, Chief Technology Officer | SOpen-market sale Common Stock | -373 | $20.95 | $7,815 | 94,826 | 33 d ago |
| Sep 9, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | SOpen-market sale Common Stock | -297 | $20.95 | $6,223 | 127,737 | 33 d ago |
| Aug 13, 2026 | Barry L Templin EVP, Chief Technology Officer | AGrant or award Common Stock | +26,246 | $0.00 | $0 | 95,199 | Aug 14, 2026 |
| Aug 13, 2026 | Kevin Waters EVP, CFO | AGrant or award Common Stock | +29,527 | $0.00 | $0 | 180,728 | Aug 14, 2026 |
| Aug 13, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | AGrant or award Common Stock | +22,965 | $0.00 | $0 | 128,034 | Aug 14, 2026 |
| Aug 13, 2026 | Pooja Sharma Chief Strat/Marketing Officer | AGrant or award Common Stock | +23,622 | $0.00 | $0 | 111,181 | Aug 14, 2026 |
| Aug 13, 2026 | Pooja Sharma Chief Strat/Marketing Officer | AGrant or award Stock Option (Right to Buy)derivative | +32,681 | $0.00 | $0 | 32,681 | Aug 14, 2026 |
| Aug 13, 2026 | Kevin Waters EVP, CFO | AGrant or award Stock Option (Right to Buy)derivative | +40,851 | $0.00 | $0 | 40,851 | Aug 14, 2026 |
| Aug 13, 2026 | Barry L Templin EVP, Chief Technology Officer | AGrant or award Stock Option (Right to Buy)derivative | +36,312 | $0.00 | $0 | 36,312 | Aug 14, 2026 |
| Aug 13, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | AGrant or award Stock Option (Right to Buy)derivative | +31,773 | $0.00 | $0 | 31,773 | Aug 14, 2026 |
| Aug 7, 2026 | Larry L Wood President, CEO | POpen-market purchase Common Stockindirect: The Larry Wood Trust | +23,900 | $20.85 | $498k | 23,900 | Aug 10, 2026 |
| Jun 8, 2026 | Kevin Waters EVP, CFO | SOpen-market sale Common Stock | -357 | $28.48 | $10k | 151,201 | Jun 10, 2026 |
| Jun 9, 2026 | Amy M. Dodrill director | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 10,941 | Jun 10, 2026 |
| Jun 9, 2026 | Mary Garrett director | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 17,700 | Jun 10, 2026 |
| Jun 9, 2026 | Frederic H Moll director | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 866,474 | Jun 10, 2026 |
| Jun 9, 2026 | Taylor C. Harris director | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 102,491 | Jun 10, 2026 |
| Jun 9, 2026 | Elisabeth Sandoval Little director | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 15,876 | Jun 10, 2026 |
| Jun 8, 2026 | Barry L Templin EVP, Chief Technology Officer | SOpen-market sale Common Stock | -358 | $28.48 | $10k | 68,953 | Jun 10, 2026 |
| Jun 9, 2026 | Thomas M Prescott director | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 7,211 | Jun 10, 2026 |
| Jun 9, 2026 | Dan Puckett director | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 8,791 | Jun 10, 2026 |
| Jun 9, 2026 | Antal Rohit Desai director | AGrant or award Common Stock | +3,315 | $0.00 | $0 | 38,467 | Jun 10, 2026 |
| Jun 8, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | SOpen-market sale Common Stock | -285 | $28.48 | $8,117 | 105,069 | Jun 10, 2026 |
| Jun 9, 2026 | Antal Rohit Desai director | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Jun 9, 2026 | Amy M. Dodrill director | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Jun 9, 2026 | Mary Garrett director | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Jun 9, 2026 | Taylor C. Harris director | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Jun 9, 2026 | Elisabeth Sandoval Little director | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Jun 9, 2026 | Frederic H Moll director | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Jun 9, 2026 | Thomas M Prescott director | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Jun 9, 2026 | Dan Puckett director | AGrant or award Stock Option (Right to Buy)derivative | +5,853 | $0.00 | $0 | 5,853 | Jun 10, 2026 |
| Mar 19, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | SOpen-market sale Common Stock10b5-1 | -3,031 | $25.82 | $78k | 107,686 | Mar 19, 2026 |
| Mar 17, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | SOpen-market sale Common Stock | -304 | $28.15 | $8,559 | 110,717 | Mar 19, 2026 |
| Mar 17, 2026 | Kevin Waters EVP, CFO | SOpen-market sale Common Stock | -706 | $28.15 | $20k | 151,558 | Mar 19, 2026 |
| Mar 19, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | SOpen-market sale Common Stock10b5-1 | -2,332 | $26.15 | $61k | 105,354 | Mar 19, 2026 |
| Mar 10, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | SOpen-market sale Common Stock10b5-1 | -3,098 | $25.60 | $79k | 111,166 | Mar 12, 2026 |
| Mar 10, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | SOpen-market sale Common Stock10b5-1 | -145 | $26.74 | $3,877 | 111,021 | Mar 12, 2026 |
| Mar 5, 2026 | Dan Puckett director | AGrant or award Common Stock | +5,476 | $0.00 | $0 | 5,476 | Mar 9, 2026 |
| Mar 5, 2026 | Larry L Wood President, CEO | AGrant or award Common Stock | +127,783 | $0.00 | $0 | 313,378 | Mar 9, 2026 |
| Mar 5, 2026 | Antal Rohit Desai director | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +142,498 | $25.44 | $3.6M | 142,498 | Mar 9, 2026 |
| Mar 5, 2026 | Kevin Waters EVP, CFO | AGrant or award Common Stock | +47,462 | $0.00 | $0 | 158,985 | Mar 9, 2026 |
| Mar 5, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | AGrant or award Common Stock | +43,811 | $0.00 | $0 | 121,156 | Mar 9, 2026 |
| Mar 6, 2026 | Alaleh Nouri EVP, CLO, CORP. SEC. | SOpen-market sale Common Stock | -6,892 | $23.70 | $163k | 114,264 | Mar 9, 2026 |
| Mar 6, 2026 | Kevin Waters EVP, CFO | SOpen-market sale Common Stock | -6,721 | $23.70 | $159k | 152,264 | Mar 9, 2026 |
| Mar 5, 2026 | Larry L Wood President, CEO | AGrant or award Stock Option (Right to Buy)derivative | +103,653 | $0.00 | $0 | 103,653 | Mar 9, 2026 |
| Mar 5, 2026 | Dan Puckett director | AGrant or award Stock Option (Right to Buy)derivative | +8,897 | $0.00 | $0 | 8,897 | Mar 9, 2026 |
| Mar 5, 2026 | Antal Rohit Desai director | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +24,748 | $26.41 | $654k | 167,246 | Mar 9, 2026 |
| Mar 6, 2026 | Antal Rohit Desai director | POpen-market purchase Common Stockindirect: Kestrel Fund, L.P. | +106,554 | $23.33 | $2.5M | 273,800 | Mar 9, 2026 |
50 of 156 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Antal Rohit Desaidirector
- Amy M. Dodrilldirector
- Mary Garrettdirector
- Taylor C. Harrisceo, officer, director
- Elisabeth Sandoval Littledirector
- Frederic H Molldirector, owner
- Michael Mackdirector
- Alaleh NouriEVP, CLO, CORP. SEC.
- Thomas M Prescottdirector
- Dan Puckettdirector
- Pooja SharmaChief Strat/Marketing Officer
- Hisham ShiblaqEVP, Chief Comm. Officer
- Barry L TemplinEVP, Chief Technology Officer
- Kevin WatersEVP, CFO
- Larry L WoodPresident, CEO
- Reza ZadnoPresident, CEO
Questions about PRCT
Answered from the filings on this page, as of the latest one.
Are insiders buying PRCT?
As of Oct 5, 2026, SEC Form 4 filings show 1 open-market buy worth $498k by 1 insider and 3 open-market sells worth $22k by 3 insiders at PROCEPT BioRobotics Corp in the last 90 days, net +$476k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade PRCT on the open market?
Alaleh Nouri (EVP, CLO, CORP. SEC.) sold $6,223 of PRCT on Sep 9, 2026 and filed the Form 4 on Sep 10, 2026. InsiderTell scored 30 (weak), with 3 insiders on the same side within 14 days.
How many insiders file Form 4 at PROCEPT BioRobotics Corp?
16 people have filed a Form 4 at PROCEPT BioRobotics Corp, among them Antal Rohit Desai (director), Amy M. Dodrill (director), Mary Garrett (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.